Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice

Journal of Nutritional Biochemistry

Volumn 23, Issue 1, 2012, Pages 51-59

  Neyrinck, Audrey M ^a   Possemiers, Sam ^b   Verstraete, Willy ^b   De Backer, Fabienne ^a   Cani, Patrice D ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Chitin glucan; Clostridial cluster XIVa; High fat diet; Microbiota; Obesity; Roseburia; Steatosis

Indexed keywords

CHITIN; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCAN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREBIOTIC AGENT; PROGLUCAGON; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM; BACTEROIDES; BIFIDOBACTERIACEAE; BODY FAT; CALORIC INTAKE; CECUM; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; EPIDIDYMIS FAT; EUBACTERIUM RECTALE; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INTESTINE FLORA; INTRAABDOMINAL FAT; LACTOBACILLUS; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; OBESITY; PREVOTELLA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ROSEBURIA; SUBCUTANEOUS FAT; WEIGHT GAIN;

ANIMALS; CHITIN; DIET, HIGH-FAT; DIETARY FIBER; DIETARY SUPPLEMENTS; FATTY LIVER; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; GLUCANS; GLUCOSE; GLUCOSE INTOLERANCE; GRAM-POSITIVE BACTERIA; HYPERGLYCEMIA; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PROGLUCAGON; TRIGLYCERIDES; WEIGHT GAIN;

MUS; ROSEBURIA;

EID: 83355164522     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.10.008     Document Type: Article

References (40)

1. Leclercq I.A., Da Silva M.A., Schroyen B., Van H.N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 2007, 47:142-156.
2. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118:2992-3002.
3. Utzschneider K.M., Kahn S.E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006, 91:4753-4761.
4. Cani P.D., Delzenne N.M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009, 9:737-743.
5. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15:1546-1558.
6. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
7. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
8. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3:213-223.
9. Cani P.D., Possemiers S., Van de W.T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
10. Daubioul C.A., Taper H.S., De Wispelaere L.D., Delzenne N.M. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats. J Nutr 2000, 130:1314-1319.
11. Delzenne N.M., Williams C.M. Prebiotics and lipid metabolism. Curr Opin Lipidol 2002, 13:61-67.
12. Delzenne N.M. Oligosaccharides: state of the art. Proc Nutr Soc 2003, 62:177-182.
13. Delmee E., Cani P.D., Gual G., Knauf C., Burcelin R., Maton N., et al. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 2006, 79:1007-1013.
14. Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006, 55:1484-1490.
15. Latge J.P. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007, 66:279-290.
16. Neyrinck A.M., Bindels L.B., De B.F., Pachikian B.D., Cani P.D., Delzenne N.M. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. Int Immunopharmacol 2009, 9:767-773.
17. Yao H.T., Chiang M.T. Chitosan shifts the fermentation site toward the distal colon and increases the fecal short-chain fatty acids concentrations in rats. Int J Vitam Nutr Res 2006, 76:57-64.
18. Simunek J., Tishchenko G., Hodrova B., Bartonova H. Effect of chitosan on the growth of human colonic bacteria. Folia Microbiol (Praha) 2006, 51:306-308.
19. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
20. de Wiele T.V., Boon N., Possemiers S., Jacobs H., Verstraete W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 2004, 51:143-153.
21. Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., et al. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 2006, 136:1862-1867.
22. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009, 101:541-550.
23. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166-1177.
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
25. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
27. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
28. Aam B.B., Heggset E.B., Norberg A.L., Sorlie M., Varum K.M., Eijsink V.G. Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 2010, 8:1482-1517.
29. Berecochea-Lopez A., Decorde K., Ventura E., Godard M., Bornet A., Teissedre P.L., et al. Fungal chitin-glucan from Aspergillus niger efficiently reduces aortic fatty streak accumulation in the high-fat fed hamster, an animal model of nutritionally induced atherosclerosis. J Agric Food Chem 2009, 57:1093-1098.
30. Wydro P., Krajewska B., Hac-Wydro K. Chitosan as a lipid binder: a Langmuir monolayer study of chitosan-lipid interactions. Biomacromolecules 2007, 8:2611-2617.
31. Backhed F., Crawford P.A. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochim Biophys Acta 2010, 1801:240-245.
32. Ridlon J.M., Kang D.J., Hylemon P.B. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006, 47:241-259.
33. Delzenne N.M., Daubioul C., Neyrinck A., Lasa M., Taper H.S. Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 2002, 87(Suppl 2):S255-S259.
34. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723.
35. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58:1509-1517.
36. Pryde S.E., Duncan S.H., Hold G.L., Stewart C.S., Flint H.J. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002, 217:133-139.
37. Ley R.E. Obesity and the human microbiome. Curr Opin Gastroenterol 2010, 26:5-11.
38. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
39. Devillard E., McIntosh F.M., Duncan S.H., Wallace R.J. Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J Bacteriol 2007, 189:2566-2570.
40. Benjamin S., Spener F. Conjugated linoleic acids as functional food: an insight into their health benefits. Nutr Metab (Lond) 2009, 6:36.